Copia Wealth Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Copia Wealth Management's FLGT Position: Q3 2026 in Review
Copia Wealth Management held its Fulgent Genetics (FLGT) position steady in Q3 2026 at 10 shares worth $221. The position accounts for ﹤0.01% of the portfolio, ranked #566.
Copia Wealth Management first reported a position in FLGT in Q4 2024 and has held it in 8 quarters since. The position peaked at $263 in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Copia Wealth Management held 10 shares of Fulgent Genetics worth $221 as of Q3 2026.
- Copia Wealth Management left its Fulgent Genetics share count unchanged in Q3 2026.
- Fulgent Genetics made up ﹤0.01% of Copia Wealth Management's portfolio in Q3 2026, its #566 holding.
- Copia Wealth Management first reported a position in Fulgent Genetics in Q4 2024 and has held it in 8 quarters since.
- Copia Wealth Management's Fulgent Genetics position peaked at $263 in Q4 2025.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Copia Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.